Patients With Metastatic Colorectal Cancer Harboring Certain BRAF Mutations May Respond to Anti-EGFR Therapy
PHILADELPHIA – Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as...
PHILADELPHIA – Patients with metastatic colorectal cancer harboring a subset of non-V600 mutations in the BRAF gene, known as...
PHILADELPHIA: – The American Association for Cancer Research (AACR) has announced Steven R. Patierno, PhD, as the recipient of...
Test employs error correction to increase accuracy PHILADELPHIA – A new liquid biopsy test could detect microsatellite instability (MSI)...
PHILADELPHIA – The PARP inhibitor olaparib (Lynparza) in combination with the chemotherapeutic agent temozolomide (Temodar) showed clinical efficacy in...
PHILADELPHIA – Incorporation of pan-cancer microsatellite instability (MSI) detection into the 74-gene panel Guardant360 liquid biopsy assay showed high...
Now accepting submissions for publication PHILADELPHIA – The American Association for Cancer Research (AACR) is launching a new journal,...
PHILADELPHIA – Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer,...
SAN FRANCISCO – A nonengineered, multiantigen-specific T-cell therapy was safe, tolerable, and showed signs of clinical activity in patients...
PHILADELPHIA – The American Association for Cancer Research (AACR) announces a call for nominations for its collection of prestigious...
PHILADELPHIA – A risk prediction model developed using clinical and radiological features could stratify individuals presenting with a lung...